HULIO

This brand name is authorized in Austria, Croatia, Ecuador, Estonia, Finland, France, Germany, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain.

Active ingredients

The drug HULIO contains one active pharmaceutical ingredient (API):

1	Adalimumab UNII FYS6T7F842 - ADALIMUMAB
	Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 0.1-0.2 nM).
	Read more about Adalimumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AB04	Adalimumab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	14338613, 14338642, 14338719, 14338725, 14338754, 15391673, 15391696, 15391710, 15391727, 15395613, 15395636, 15395642, 15395659, 15530034, 15530040, 15530057, 15530063, 15617137, 15617143, 15617166, 15617172, 15629695, 15629703, 15637051, 15637068, 15637074, 15637080, 15639357, 15639386, 15659070, 15659087, 15817675, 15817681, 15862960, 15862977, 15863008, 15863014, 16011425, 16013878, 16013967, 16013973, 16022802, 16022819, 16022825, 16022831, 16702299, 16702307, 16759483, 16759508, 16759514, 16759520, 16759603, 16801392, 16801423, 16868611, 17147368, 17147374, 17231672, 17312531, 17848409, 17904639, 17904645
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	176-MBE-0221
EE	Ravimiamet	1780141, 1780152, 1780163, 1780174, 1780185, 1780196, 1780208, 1836266, 1836277
ES	Centro de información online de medicamentos de la AEMPS	1181319002, 1181319005
FI	Lääkealan turvallisuus- ja kehittämiskeskus	096122, 145866, 399119, 479515
FR	Base de données publique des médicaments	62042376, 63895021, 68311292
IE	Health Products Regulatory Authority	88938, 88955, 88956
IL	מִשְׂרַד הַבְּרִיאוּת	9095, 9096
IT	Agenzia del Farmaco	047088012, 047088024, 047088036, 047088048, 047088051, 047088063, 047088075, 047088087, 047088099, 047088101, 047088113, 047088125, 047088137, 047088149, 047088152, 047088164, 047088176, 047088188, 047088190, 047088202
LT	Valstybinė vaistų kontrolės tarnyba	1086227, 1086228, 1086229, 1086230, 1086231, 1086232, 1086233, 1087057, 1092695, 1092696, 1093477, 1093478, 1093479, 1093480, 1093481, 1093482, 1093483, 1093484, 1093485, 1093486
NL	Z-Index G-Standaard, PRK	106348, 84492
PL	Rejestru Produktów Leczniczych	100409708, 100467435
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64885001, W64886001, W64886002, W64886003, W64887001, W64887002, W64887003